About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2722 blog entries.

New York

NYRx, the State Department of Health Medicaid Pharmacy Benefit Program, released updates to the NYRx Prior Authorization Programs and updated preferred drug list, changes were effective December 14. 

The State Department of Health also released a reminder regarding pharmacy providers and members out-of-pocket costs. This communication was sent to all pharmacies to remind them of their responsibility for continued enrollment, to adhere to the policies and procedures of the Medicaid Program. Specifically, it is inappropriate to allow an eligible member to pay out-of-pocket for services that are covered by NY Medicaid (NYRx) beyond copay. Please be advised that out-of-pocket expenses are only reimbursable by Medicaid for Medicaid covered services when one of these three situations applies:  

  • Reimbursement can be made for both participating and non-participating Medicaid Providers during the three-month retro period up until they submit the application. 
  • Reimbursement can be made for only Medicaid participating Providers from the date the application is submitted up until they receive the Common Benefit Identification Card (CBIC). 
  • Reimbursement can be made for both participating and non-participating Medicaid Providers due to agency error or delay. 

If there is an eligibility issue that is corrected in a timely manner, pharmacists should resubmit the claim when the issue is resolved and reimburse the member directly if the member paid out of pocket. There is support available to pharmacists to assist with claim issues. Questions regarding this communication may be directed to NYRx@health.ny.gov. 

On December 12, A6779, a bill NACDS and the Community Pharmacy Association of New York (CPANY) had been supporting to expand the 2022 law allowing pharmacists to administer long-acting injectables, was sent to the Governor's desk by the legislature. Gov. Kathy Hochul (D) has until December 22 to act on the legislation. 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2023-12-15T10:35:02-05:00December 15, 2023|New York|

Ohio

The Board of Pharmacy published a series of proposed rule changes and rescissions they intend to work on this winter. Comments are due to the board on January 17, 2024.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-15T10:33:49-05:00December 15, 2023|Ohio|

Oklahoma

The Tenth Circuit Court of Appeals denied the State of Oklahoma’s petition for rehearing in PCMA v. Mulready. The state now has 90 days to petition the Supreme Court for further review. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-12-15T10:33:11-05:00December 15, 2023|Oklahoma|

Texas

The Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) now covers the 2023-2024 Pfizer-BioNTech, Moderna and Novavax commercial COVID-19 vaccines as a pharmacy benefit for both Medicaid managed care and fee-for-service, as well as the Children's Health Insurance Program (CHIP). 

Also in Texas, Medicaid will perform the semi-annual update of the Medicaid preferred drug list on January 25, 2024. The Health and Human Services Commission (HHSC) made the PDL changes based on recommendations made at the October 2023 Drug Utilization Review Board meeting. Drug list recommendations from the meeting are available. Drugs with preferred status drugs may include brand name medication which would not require a PDL prior authorization nor the value of "1" in the "Dispense as Written (DAW) Product Selection code" field (408-D8). Refer to the Dispense as Written section of the Formulary Coverage chapter of the Pharmacy Provider Procedure Manual for more information. 

Also in Texas, the Health and Human Services Commission (HHSC) is soliciting comments on the prospective clinical prior authorization proposals likely to be presented at the Texas Drug Utilization Review (DUR) Board meeting on January 26, 2024. The board reviews and recommends clinical criteria and the preferred or non-preferred drug status on the Medicaid formulary.  

Also in Texas, December 11 was the filing deadline for the March 5, 2024, primary election.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-12-15T10:31:53-05:00December 15, 2023|Texas|

Vermont

The Board of Pharmacy is scheduled to hold its regular meeting on December 20; the agenda has been posted.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2023-12-15T10:31:11-05:00December 15, 2023|Vermont|

Washington

Gov. Jay Inslee (D) hosted a roundtable this week to discuss the fentanyl crisis and laid out his proposals for the upcoming legislative session. The governor’s budget adds over $50 million in new funding to take down opioids for the 2023–25 biennium, augmenting the investments from the state’s $82 million opioid settlements with drug manufacturers and pharmacies responsible in part for the opioid crisis and general fund investments within the 2023–25 biennial budget. The biennial budget allocated over $200 million for substance use disorder (SUD) treatment facility operations, rental subsidies for people with SUD, treatment subsidies, criminal diversion programs, peer support services, Tribal SUD grants and more.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-12-15T10:30:35-05:00December 15, 2023|Washington|

Alaska

The Board of Pharmacy is meeting on November 16. The agenda and public packet are available on the Board’s website.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-11-17T11:08:41-05:00November 17, 2023|Alaska|

Arkansas

Candidates interested in running for state and federal offices in 2024 filed for office on November 6 through 14, 2023. At the top of the ballot will be the Presidential race, then the four U.S. Congressional House of Representatives seats, plus eighteen members of the thirty-five member Arkansas Senate, all one hundred members of the Arkansas House of Representatives. The primary election date is March 5, 2024, followed by the runoff on April 2, 2024, and the general election on November 5, 2024.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-11-17T11:08:07-05:00November 17, 2023|Arkansas|

California

2023-11-17T11:07:35-05:00November 17, 2023|California|
Go to Top